The mode of action of a novel 18-membered macrolide, virustomycin A (AM-2604A), on Trichomonas foetus.
- 1 January 1983
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 36 (12) , 1755-1761
- https://doi.org/10.7164/antibiotics.36.1755
Abstract
The mode of action of virustomycin A, a novel 18-membered macrolide, on T. foetus was investigated. The antibiotic inhibited the biosynthesis of RNA, DNA and protein in the organism. The inhibition of RNA biosynthesis was the most severe. Virustomycin A repressed the incorporation of [3H]uridine into both acid-soluble and insoluble fractions, whereas actinomycin D inhibited the incorporation of [3H]uridine into acid-insoluble fraction alone. Virustomycin A interfered with nucleotide formation from uridine and adenosine but not with their transport to the cells. The antibiotic did not inhibit the activities of uridine kinase and uracil phosphoribosyltransferase in a cell-free extract from the organism. Probably, it interferes with the formation of phosphate donor(s) (possibly ATP-forming system) of the organism.This publication has 0 references indexed in Scilit: